inflammation/albumin

Povezava se shrani v odložišče

Izberite vrsto razvrščanja

12 rezultatov

Method for producing albumin conjugates containing gyrase inhibitors

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

FIELD OF THE INVENTION The present invention concerns gyrase inhibitor-protein conjugates and in particular gyrase inhibitor-albumin conjugates, pharmaceutical preparations comprising gyrase inhibitor-protein conjugates in particular for the treatment and/or prophylaxis of inflammatory processes

Biomarkers for inflammation of the liver

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn.371) of PCT/DE2007/001427, filed Aug. 10, 2007, which claims benefit of German application 102006037613.7, filed Aug. 10, 2006 and German application 102006048249.2, filed Oct. 12, 2006. DESCRIPTION The

Nanoparticle carrier systems based on human serum albumin for photodynamic therapy

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to drug formulation of hydrophobic photosensitizer. In particular, the invention relates to nanoparticle formulations containing hydrophobic photosensitizers, to their method of preparation and to their use in

Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

FIELD OF THE INVENTION The present invention relates generally to compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease. BACKGROUND OF THE INVENTION Neutrophil adhesion to activated endothelial cells and trans-endothelial migration of these cells are essential

Method for measuring activity of a specific fraction of albumin

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND OF THE INVENTION The inflammatory response governs a wide range of illness from injury to infections and allergies. Initiating inflammation involves activating immune cells that trigger the phospholipase A.sub.2 (PLA.sub.2)-involved inflammatory processes. PLA.sub.2 enzymes are a diverse

Natural pharmaceutical preparations for increasing albumin

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND OF THE PRESENT INVENTION 1. Field of Invention The subject invention relates generally to a series of natural pharmaceutical preparations which can treat hypoproteinemia for increasing albumin. The preparations could be used to treat hypoproteinemia caused by hepatitis virus, human

Antibodies to IL-6 to inhibit or treat inflammation

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety. BACKGROUND 1. Field of the Art This invention is an extension of Applicants' prior invention disclosed in the above-referenced

Human immunosuppressive protein

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND 1. Technical Field The invention is in the fields of drug therapy; more specifically, the invention encompasses a protein for immunosuppression. 2. The Prior Art The central nervous system (CNS) actively maintains immune privilege (Carson and Sutcliffe, 1999; Fabry et al., 1994), in part

Method for treating allergic dermatitis

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

FIELD OF THE INVENTION The present disclosure relates to the treatment of allergic dermatitis, and in particular to allergic dermatitis resulting from contact with naturally-occurring hydrophobic toxins such as urushiol and isosolenopsin A. BACKGROUND OF THE INVENTION Allergic dermatitis can be

Leukotriene by amides and hydrazides

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

RELATIONSHIP TO THE PRIOR ART The concept of using conjugates of leukotrienes in a radioimmunoassay was described, by L. Levine, R. A. Morgan, R. A. Lewis, K. F. Austin, D. A. Clark, A. Marfat, and E. J. Corey, Proceeding of the National Academy of Sciences, U.S.A., Vol. 78, No. 12 7692 (1981) This

Conjugates of leukotrienes with proteins

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Anti-tumor necrosis factor-alpha agents and uses thereof

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

FIELD OF THE INVENTION The present invention relates to anti-Tumor Necrosis Factor polypeptides comprising one or more antibody single variable domains, or antigen-binding fragments thereof, in particular, dimers comprising two light chain variable domains that have high solubility. It also relates

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah